In an investigation into the roles of RAGE in GC pathogenesis and progression and the effects of its gene polymorphisms on receptor function, Gu and colleagues [13] have demonstrated that RAGE Gly82Ser polymorphism may be associated with an increased risk of initiation or progression of gastric carcinoma. This evidence concerns the gene AGER and gastric cancer.